Stock screenerAll disclosures →
EDGAR →
IQV
Conviction 62HealthcareScan · Mon, Jul 20, 2026IQV$203.95-1.12%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 1.23M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price203.95
Change-1.12%
Gap-1.04%
Rel volume0.72×
Avg volume1.37M
Avg $ vol269.69M
SMA 20198.84
SMA 50185.39
SMA 200196.63
Price vs 50+10.01%
Price vs 200+3.72%
MA stackmixed
50/200 cross—
Supertrendup · 190.89
RSI (14)59
MACD hist-0.33
MACD crossbear · 0d
Stoch %K / %D64 / 77
ADX (14)27
+DI / −DI28 / 20
RSI divergence—
MACD divergence—
ATR %+3.06%
ADR %3.09%
52w high244.29
52w low156.66
From 52w high-16.51%
Above 52w low+30.19%
New 52w highNo
SqueezeOff
Bollinger width24.82%
%B0.60
Donchian pos82.84%
Donchian high212.36
Donchian low163.35
AVWAP (52w high)181.06
vs AVWAP high+12.64%
AVWAP (52w low)180.16
vs AVWAP low+13.20%
OBV trendUp
Chaikin MF (20)0.21
Today vs 20d0.72×
Avg vol (14d)1.23M
Avg vol (20d)1.37M
Avg $ vol (20d)269.69M
Market cap34.04B
RS 3m (vs SPY)+14.02%
RS 6m (vs SPY)-22.21%
RS line new highNo
Trend template6/8
Technical rank57.2
1 week-1.73%
1 month+19.50%
3 months+15.58%
6 months-15.47%
1 year+24.93%
YTD-9.50%
P/E25.03
P/B5.47
P/S2.09
P/FCF16.60
EPS7.84
Div yield1.67%
ROE21.86%
ROA4.58%
Debt/Eq2.55
Current0.75
EV/EBITDA14.41
Gross margin—
Net margin8.34%
Rev growth5.87%
EPS growth-0.95%
Price target223.80
Target upside9.73%
Analyst ratingBuy
Institutional108.53%
Ent. value47.93B
Revenue4.15B
Net income274M
Gross profit915M
Free cash flow2.05B
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNYSE
Shares out—
Employees93K
ListedThu, May 9, 2013
Free float160.54M
Float %94.6%
Short interest4.98M
Days to cover2.7d
Short volume69.4%
Squeeze score40 / 100
Next earningsTue, Jul 28, 2026 · pre-mkt (8d)
EPS forecast$2.72 · 6 est
Last EPS vs est$2.64 vs $2.51
Last surprise+5.2% beat
Setup gradeB
Conviction62 / 100
Pattern quality—
Tech rank57.2 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance211.73
Support161.99
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 32 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Retesting breakoutMay 291 scan
- Setting upJun 16 – Jul 172 scans
Congress activity
Disclosed STOCK Act trades in IQV · 7 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Markwayne Mullin senate · traded 2025-12-29 | Buy | $15K–$50K | 2025-12-29 | 2026-01-16 | |
 John Boozman senate · R · AR · traded 2025-10-02 | Sell | $1K–$15K | 2025-10-02 | 2025-11-15 | |
 Rob Bresnahan house · PA · traded 2025-05-15 | Sell | $1K–$15K | 2025-05-15 | 2025-05-31 | |
Rob Bresnahan house · PA · traded 2025-04-08 | Buy | $15K–$50K | 2025-04-08 | 2025-05-08 | |
Rob Bresnahan house · PA · traded 2025-02-25 | Sell | $1K–$15K | 2025-02-25 | 2025-03-27 | |
Markwayne Mullin senate · traded 2025-02-13 | Buy | $15K–$50K | 2025-02-13 | 2025-02-27 | |
Markwayne Mullin senate · traded 2024-08-20 | Buy | $15K–$50K | 2024-08-20 | 2024-09-19 |
Insider activity
SEC Form 4 transactions in IQV · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
DANHAKL JOHN G Director · Deferred Shares · 2026-07-14 | Grant | 160 | $33K | 2026-07-14 | 2026-07-16 |
Fasano Jim Director · Deferred Shares · 2026-07-14 | Grant | 195 | $41K | 2026-07-14 | 2026-07-16 |
GOGGINS COLLEEN A Director · Deferred Shares · 2026-07-14 | Grant | 183 | $38K | 2026-07-14 | 2026-07-16 |
Wims Morris Leslie Director · Deferred Shares · 2026-07-14 | Grant | 148 | $31K | 2026-07-14 | 2026-07-16 |
GOGGINS COLLEEN A Director · Deferred Shares · 2026-05-07 | Grant | 214 | $38K | 2026-05-07 | 2026-05-11 |
Fasano Jim Director · Deferred Shares · 2026-05-07 | Grant | 228 | $41K | 2026-05-07 | 2026-05-11 |
DANHAKL JOHN G Director · Deferred Shares · 2026-05-07 | Grant | 185 | $33K | 2026-05-07 | 2026-05-11 |
Wims Morris Leslie Director · Deferred Shares · 2026-05-07 | Grant | 171 | $31K | 2026-05-07 | 2026-05-11 |
GOGGINS COLLEEN A Director · Common Stock · 2026-04-23 | Grant | 1.57K | $0 | 2026-04-23 | 2026-04-27 |
LEONARD JOHN M Director · Common Stock · 2026-04-23 | Grant | 1.57K | $0 | 2026-04-23 | 2026-04-27 |
SEC filings
EDGAR filings in IQV · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.